Search
Search
ln support of World Preeclampsia Day, we are honored to host this educational webinar, featuring Prof. Hyett, who will be sharing the latest advancements and translational approaches in the management of preeclampsia.
Additionally, he will discuss some of the best clinical practices and key recommendations for managing high-risk pregnancies. We are also thrilled to have Dr. Wataganara serve as the chairperson for this insightful event.
This is a unique opportunity to engage directly with these esteemed professionals and ask your questions in real time. A Certificate of Attendance will be provided to all participants.
1300-1305: Session Introduction, Assoc. Prof. Tuangsit Wataganara
1305-1350: Biomarkers in Preeclampsia Across Trimesters, Prof. Jon Hyett
1350-1400: Q&A, Everyone
Tuangsit Wataganara
Associate Professor, Chief, Maternal-Fetal Medicine, Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital, Mahidol University
Dr. Wataganara is an Associate Professor in the Division of Maternal-Fetal Medicine, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand. He is board-certified in both Obstetrics and Gynecology, and Maternal-Fetal Medicine. He has a special research interest in fetal diagnosis, non-invasive prenatal genetic diagnosis, bi-directional feto maternal trafficking of cell-free nucleic acids, hypertensive disorders during pregnancy and ln utero fetal surgery. He has over 95 research works with 1382 citations. He is focusing on fetal medicine with more than 30 publications in international, peer-review journals and has been invited to more than 100 international lectures in the past 10 years.
Jon Hyett
Clinical Professor, Clinical Academic in Obstetrics and Genecology, Head of MFM, South Western Sydney, Western Sydney University
Jon Hyett is the Head of the Department of Maternal and Fetal Medicine at Liverpool Hospital, Sydney and the Professor of Obstetrics and Gynaecology at Western Sydney University.
Jon's primary research interests include predictive modelling and preventative interventions for adverse obstetric outcomes. Many of these models are based on first trimester screening. Others are being developed for managing term pregnancies. He is also interested in management of multiple pregnancies. Jon is a trustee of the Fetal Medicine Foundation (UK) who have developed a number of risk algorithms used to inform management of pregnancy.